GCP
OGN icon

Gill Capital Partners’s Organon & Co OGN Stock Holding History

Gill Capital Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-25
Closed -$339 – 470
2026
Q2 		$339 Buy
+25
New +$299 ﹤0.01% 663

Other funds holding OGN

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
FIM
Fruth Investment Management Houston, Texas $409M AUM 32.01% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
AB
Atlas Brown Louisville, Kentucky $379M AUM 27.6% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Gill Capital Partners's OGN Position: Q3 2026 in Review

Gill Capital Partners sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 25 shares — an estimated $339 sold.

Gill Capital Partners first reported a position in OGN in Q2 2026 and held it in 1 quarter. The position peaked at $339 in Q2 2026. 37 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Gill Capital Partners reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
  • Gill Capital Partners sold 25 Organon & Co shares in Q3 2026, an estimated $339.
  • Gill Capital Partners first reported a position in Organon & Co in Q2 2026 and held it in 1 quarter.
  • Gill Capital Partners's Organon & Co position peaked at $339 in Q2 2026.
  • 37 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Gill Capital Partners's 13F filing for Q3 2026, filed 13 Oct 2026.